Vericel Corp (VCEL)

• Market cap: $1.7B
• 1 day: -2.66%
• 5 days: -5.42%
• 1 month: -0.3%
• 3 months: -5.74%
• 6 months: -14.14%
• Year to date: -6.4%
• 1 year: -19.4%
• 5 years: -41%
• 10 years: 1,090.36%
• Sector: Healthcare
• Industry: Biotechnology

About: Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 398